ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Amarantus forms Elto Pharma for CNS Disorders and MANF Therapeutics for Ophthalmology
April 19, 2017Amarantus Bioscience has formed a wholly-owned subsidiary named Elto Pharma for the purpose of creating investment vehicles focused exclusively on the further development of Eltoprazine... -
Amarantus Forms Subsidiaries "Elto Pharma" to Focus on CNS Disorders and "MANF Therapeutics" to Focu
April 18, 2017Amarantus Bioscience Holdings, Inc. has announced it has formed a wholly-owned subsidiary named Elto Pharma, Inc. for the purpose of further development of Eltoprazine... -
Santen and twoXAR to identify new drug candidates for glaucoma
February 28, 2017US-based ophthalmology company Santen and biopharmaceutical company twoXAR have entered a strategic research collaboration to identify new drug candidates for glaucoma.
Pharma Sources Insight January 2025
